UBX
Nuveen Asset Management’s Unity Biotechnology UBX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-136,438
| Closed | -$819K | – | 3433 |
|
|
2021
Q1 | $819K | Buy |
136,438
+23,967
| +21% | +$144K | ﹤0.01% | 2954 |
|
|
2020
Q4 | $589K | Buy |
112,471
+3,521
| +3% | +$18.4K | ﹤0.01% | 2998 |
|
|
2020
Q3 | $1.35M | Sell |
108,950
-49,930
| -31% | -$621K | ﹤0.01% | 2552 |
|
|
2020
Q2 | $1.38M | Buy |
158,880
+49,930
| +46% | +$433K | ﹤0.01% | 2485 |
|
|
2020
Q1 | $632K | Buy |
108,950
+11,362
| +12% | +$65.9K | ﹤0.01% | 2688 |
|
|
2019
Q4 | $703K | Sell |
97,588
-837
| -0.9% | -$6.03K | ﹤0.01% | 2815 |
|
|
2019
Q3 | $601K | Sell |
98,425
-4,822
| -5% | -$29.4K | ﹤0.01% | 2884 |
|
|
2019
Q2 | $981K | Buy |
+103,247
| New | +$981K | ﹤0.01% | 2741 |
|